$CWBHF
Stock $cwbhf

$cwbhf Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000175015522000100 Filed on August 09, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$17.04M	$18.88M	$19.36M
YoY Change	-28.13%	-21.84%	-17.31%
Cost Of Revenue	$8.092M	$9.556M	$7.643M
YoY Change	-7.93%	14.79%	-21.77%
Gross Profit	$8.945M	$9.321M	$11.71M
YoY Change	-40.03%	-41.11%	-14.11%
Gross Profit Margin	52.5%	49.38%	60.51%
Selling, General & Admin	$11.03M	$17.26M	$20.36M
YoY Change	-24.95%	-31.45%	-14.42%
% of Gross Profit	123.33%	185.16%	173.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.822M	$1.862M	$2.078M
YoY Change	-34.03%	-36.58%	-22.11%
% of Gross Profit	20.37%	19.98%	17.74%
Operating Expenses	$11.03M	$17.26M	$20.36M
YoY Change	-53.84%	-31.45%	-14.42%
Operating Profit	-$3.909M	-$7.938M	-$8.642M
YoY Change	-56.49%	-15.11%	-14.85%
Interest Expense	-$4.000M	$0.00	$100.0K
YoY Change	-149.55%	-100.0%	-130.3%
% of Operating Profit
Other Income/Expense, Net	$321.0K	$68.00K	-$84.00K
YoY Change	191.82%	-35.24%	-180.0%
Pretax Income	-$7.588M	-$7.870M	-$8.626M
YoY Change	731.11%	32.78%	-32.29%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.588M	-$7.870M	-$8.626M
YoY Change	731.11%	32.87%	-32.47%
Net Earnings / Revenue	-44.54%	-41.69%	-44.56%
Basic Earnings Per Share	-$0.05	-$0.05	-$0.06
Diluted Earnings Per Share	-$0.05	-$0.05	-$0.06
COMMON SHARES
Basic Shares Outstanding	145.5M shares	145.2M shares	145.0M shares
Diluted Shares Outstanding	145.3M shares	145.2M shares	145.0M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.51M	$14.82M	$14.50M
YoY Change	-21.62%	-45.32%	-58.58%
Cash & Equivalents	$16.51M	$14.82M	$14.50M
Short-Term Investments
Other Short-Term Assets	$4.530M	$4.390M	$6.782M
YoY Change	-49.69%	-44.83%	35.64%
Inventory	$50.60M	$52.63M	$53.06M
Prepaid Expenses
Receivables	$2.044M	$2.455M	$2.654M
Other Receivables	$495.0K	$8.074M	$10.71M
Total Short-Term Assets	$74.18M	$82.37M	$87.70M
YoY Change	-33.34%	-28.68%	-27.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.09M	$32.92M	$34.45M
YoY Change	-48.96%	-45.76%	-44.26%
Goodwill
YoY Change
Intangibles	$2.018M	$2.337M	$2.604M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.016M	$1.898M	$1.974M
YoY Change	-60.2%	-80.51%	-81.55%
Total Long-Term Assets	$66.34M	$70.65M	$73.12M
YoY Change	-62.2%	-58.56%	-58.12%
TOTAL ASSETS
Total Short-Term Assets	$74.18M	$82.37M	$87.70M
Total Long-Term Assets	$66.34M	$70.65M	$73.12M
Total Assets	$140.5M	$153.0M	$160.8M
YoY Change	-51.0%	-46.49%	-45.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.584M	$5.122M	$5.147M
YoY Change	-65.88%	-14.97%	-16.98%
Accrued Expenses	$7.435M	$7.304M	$6.609M
YoY Change	-24.22%	-24.34%	-16.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.128M	$5.365M	$6.038M
YoY Change	-48.89%	-36.22%	-44.61%
Total Short-Term Liabilities	$13.15M	$17.79M	$17.79M
YoY Change	-44.07%	-26.15%	-30.22%
LONG-TERM LIABILITIES
Long-Term Debt	$18.51M	$19.30M	$19.87M
YoY Change	-12.02%	-1.65%	-0.67%
Other Long-Term Liabilities	$2.000K	$12.00K	$12.00K
YoY Change	-99.23%	-99.6%	-99.85%
Total Long-Term Liabilities	$2.000K	$12.00K	$12.00K
YoY Change	-99.99%	-99.95%	-99.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.15M	$17.79M	$17.79M
Total Long-Term Liabilities	$2.000K	$12.00K	$12.00K
Total Liabilities	$31.66M	$37.10M	$37.67M
YoY Change	-29.34%	-20.55%	-29.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$212.7M	-$205.1M	-$197.2M
YoY Change
Common Stock	$1.000K	$1.000K	$1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$108.9M	$115.9M	$123.2M
YoY Change
Total Liabilities & Shareholders Equity	$140.5M	$153.0M	$160.8M
YoY Change	-51.0%	-46.49%	-45.59%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$7.588M	-$7.870M	-$8.626M
YoY Change	731.11%	32.87%	-32.47%
Depreciation, Depletion And Amortization	$1.822M	$1.862M	$2.078M
YoY Change	-34.03%	-36.58%	-22.11%
Cash From Operating Activities	$1.685M	$395.0K	-$4.679M
YoY Change	-123.54%	-104.69%	-46.26%
INVESTING ACTIVITIES
Capital Expenditures	-$78.00K	-$62.00K	-$271.0K
YoY Change	-90.49%	-95.99%	-84.24%
Acquisitions
YoY Change
Other Investing Activities	$354.0K	$0.00	$0.00
YoY Change	197.48%	-100.0%	-100.0%
Cash From Investing Activities	$276.0K	-$62.00K	-$271.0K
YoY Change	-139.37%	-95.3%	-97.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-265.0K	-13.00K	-$47.00K
YoY Change	-114.47%	-100.72%	-393.75%
NET CHANGE
Cash From Operating Activities	1.685M	395.0K	-$4.679M
Cash From Investing Activities	276.0K	-62.00K	-$271.0K
Cash From Financing Activities	-265.0K	-13.00K	-$47.00K
Net Change In Cash	1.696M	320.0K	-$4.997M
YoY Change	-128.14%	-104.03%	-71.86%
FREE CASH FLOW
Cash From Operating Activities	$1.685M	$395.0K	-$4.679M
Capital Expenditures	-$78.00K	-$62.00K	-$271.0K
Free Cash Flow	$1.763M	$457.0K	-$4.408M
YoY Change	-127.82%	-106.64%	-36.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Registrant Name EntityRegistrantName	Charlotte's Web Holdings, Inc.
	dei	Entity File Number EntityFileNumber	000-56364
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1508633
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001750155
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1801 California Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 4800
	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80202
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	617-7303
	dei	Security12g Title Security12gTitle	Common stock, no par value
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	145453442	shares
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14817000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2549000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19494000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2455000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4882000	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	495000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	495000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	52631000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	52077000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4390000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8095000	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7579000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	10764000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	82367000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	95807000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32917000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36085000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19358000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20679000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2337000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2843000	usd
CY2022Q2	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13100000	usd
CY2021Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13000000	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1037000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1037000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1898000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2062000	usd
CY2022Q2	us-gaap	Assets Assets	153014000	usd
CY2021Q4	us-gaap	Assets Assets	171513000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5122000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5049000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7304000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9570000	usd
CY2022Q2	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	2957000	usd
CY2021Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	3448000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2408000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2103000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	17791000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20170000	usd
CY2022Q2	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	0	usd
CY2021Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	385000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19299000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20500000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	37102000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	41067000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	145278165	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	145278165	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	144659964	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	144659964	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q2	cweb	Proportionate Voting Stock Value Issued ProportionateVotingStockValueIssued	0	usd
CY2021Q4	cweb	Proportionate Voting Stock Value Issued ProportionateVotingStockValueIssued	0	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	321021000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	319059000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-205110000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188614000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	115912000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130446000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	153014000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	171513000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18877000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24152000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38234000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47559000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9556000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8325000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17199000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18095000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	9321000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	15827000	usd
	us-gaap	Gross Profit GrossProfit	21035000	usd
	us-gaap	Gross Profit GrossProfit	29464000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17259000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25178000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	37614000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48964000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7938000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9351000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16579000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19500000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	68000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	105000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	210000	usd
CY2022Q2	cweb	Change In Fair Value Of Financial Instruments And Other Gain Loss ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss	0	usd
CY2021Q2	cweb	Change In Fair Value Of Financial Instruments And Other Gain Loss ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss	3319000	usd
	cweb	Change In Fair Value Of Financial Instruments And Other Gain Loss ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss	100000	usd
	cweb	Change In Fair Value Of Financial Instruments And Other Gain Loss ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss	623000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7870000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5927000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16496000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18667000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-7870000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5923000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16496000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18697000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145168510	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145168510	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139936443	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139936443	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145079859	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145079859	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139817622	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139817622	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130446000	usd
CY2022Q1	cweb	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	165000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-2000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1214000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-8626000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	123152000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	643000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-7870000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	115912000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	254242000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30000	usd
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	112000	usd
CY2021Q1	cweb	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	441000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	832000	usd
CY2021Q1	cweb	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	360000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12774000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	243019000	usd
CY2021Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	26000	usd
CY2021Q2	cweb	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	363000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	839000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	994000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5923000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	239266000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16496000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18697000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3940000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5466000	usd
	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	100000	usd
	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	613000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-2000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	515000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1857000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	178000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2022000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2549000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-150000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-93000	usd
	cweb	Settlement Of Cultivation Liability SettlementOfCultivationLiability	582000	usd
	cweb	Settlement Of Cultivation Liability SettlementOfCultivationLiability	0	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1236000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1309000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2430000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-601000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2411000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	315000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3706000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-589000	usd
	cweb	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability	896000	usd
	cweb	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability	1288000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2194000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1825000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-3185000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-540000	usd
	cweb	Increase Decrease In Cultivation Liabilities IncreaseDecreaseInCultivationLiabilities	-323000	usd
	cweb	Increase Decrease In Cultivation Liabilities IncreaseDecreaseInCultivationLiabilities	-5243000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-194000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	26000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4284000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16167000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	333000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3268000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	9000	usd
	cweb	Payments To Acquire Notes Receivable Net Of Proceeds From Collection PaymentsToAcquireNotesReceivableNetOfProceedsFromCollection	0	usd
	cweb	Payments To Acquire Notes Receivable Net Of Proceeds From Collection PaymentsToAcquireNotesReceivableNetOfProceedsFromCollection	363000	usd
	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	0	usd
	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-507000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-333000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10389000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	978000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-60000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-159000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-60000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	849000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4677000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25707000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19494000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52803000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14817000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27096000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2364000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1443000	usd
CY2021Q4	cweb	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	52077000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3255000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18877000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24152000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38234000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47559000	usd
CY2022Q2	cweb	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	52631000	usd
CY2022Q2	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13100000	usd
CY2021Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13000000	usd
CY2022Q2	cweb	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	5750000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.27
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4099000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	38042000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	38249000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	12760000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	15189000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16654000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13974000	usd
CY2022Q2	us-gaap	Inventory Gross InventoryGross	67456000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	67412000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	14825000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	15335000	usd
CY2022Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	10000000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1433000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3411000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2946000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2222000	usd
CY2022Q2	cweb	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	15595000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	28862000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7155000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	21707000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2408000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19299000	usd
CY2021Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	3448000	usd
CY2021Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	385000	usd
CY2021Q4	cweb	Cultivation Liabilities CultivationLiabilities	3833000	usd
	cweb	Cultivation Liability Costs Incurred Current CultivationLiabilityCostsIncurredCurrent	97000	usd
	cweb	Cultivation Liability Costs Incurred Noncurrent CultivationLiabilityCostsIncurredNoncurrent	0	usd
	cweb	Cultivation Liability Costs Incurred CultivationLiabilityCostsIncurred	97000	usd
	cweb	Cultivation Liability Settlement Payments Current CultivationLiabilitySettlementPaymentsCurrent	420000	usd
	cweb	Cultivation Liability Settlement Payments Noncurrent CultivationLiabilitySettlementPaymentsNoncurrent	0	usd
	cweb	Cultivation Liability Settlement Payments CultivationLiabilitySettlementPayments	420000	usd
	cweb	Cultivation Liability Settlement Reduction Current CultivationLiabilitySettlementReductionCurrent	582000	usd
	cweb	Cultivation Liability Settlement Reduction Noncurrent CultivationLiabilitySettlementReductionNoncurrent	0	usd
	cweb	Cultivation Liability Settlement Reduction CultivationLiabilitySettlementReduction	582000	usd
	cweb	Cultivation Liability Interest Expense Current CultivationLiabilityInterestExpenseCurrent	29000	usd
	cweb	Cultivation Liability Interest Expense Noncurrent CultivationLiabilityInterestExpenseNoncurrent	0	usd
	cweb	Cultivation Liability Interest Expense CultivationLiabilityInterestExpense	29000	usd
	cweb	Cultivation Liability Conversion To Short Term Borrowing Current CultivationLiabilityConversionToShortTermBorrowingCurrent	-385000	usd
	cweb	Cultivation Liability Conversion To Short Term Borrowing Noncurrent CultivationLiabilityConversionToShortTermBorrowingNoncurrent	385000	usd
	cweb	Cultivation Liability Conversion To Short Term Borrowing CultivationLiabilityConversionToShortTermBorrowing	0	usd
CY2022Q2	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	2957000	usd
CY2022Q2	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	0	usd
CY2022Q2	cweb	Cultivation Liabilities CultivationLiabilities	2957000	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	142335464	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	142335464	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	0	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	0	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	0	shares
CY2022Q2	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	0	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6983140	shares
CY2021Q4	cweb	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	7.86
	cweb	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
	cweb	Class Of Warrant Or Right Exercised Weighted Average Exercise Price ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice	0
	cweb	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	6983140	shares
	cweb	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	7.86
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2022Q2	cweb	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	0
CY2022Q2	cweb	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	1233140	shares
CY2022Q2	cweb	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	15.29
CY2022Q2	cweb	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	5750000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.27
	cweb	Proportionate Voting Stock Conversion Ratio ProportionateVotingStockConversionRatio	400
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-7870000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5923000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16496000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18697000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145168510	shares
CY2021Q2	cweb	Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingBasic	109435643	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145079859	shares
	cweb	Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingBasic	108833622	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q2	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic	0	shares
CY2021Q2	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic	76252	shares
	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic	0	shares
	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic	77460	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145168510	shares
CY2021Q2	cweb	Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingDiluted	109435643	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145079859	shares
	cweb	Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingDiluted	108833622	shares
CY2022Q2	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted	0	shares
CY2021Q2	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted	76252	shares
	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted	0	shares
	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted	77460	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022Q2	cweb	Earnings Per Proportionate Voting Share Diluted EarningsPerProportionateVotingShareDiluted	0
CY2022Q2	cweb	Earnings Per Proportionate Voting Share Basic EarningsPerProportionateVotingShareBasic	0
CY2021Q2	cweb	Earnings Per Proportionate Voting Share Basic EarningsPerProportionateVotingShareBasic	-16.93
CY2021Q2	cweb	Earnings Per Proportionate Voting Share Diluted EarningsPerProportionateVotingShareDiluted	-16.93
	cweb	Earnings Per Proportionate Voting Share Basic EarningsPerProportionateVotingShareBasic	0
	cweb	Earnings Per Proportionate Voting Share Diluted EarningsPerProportionateVotingShareDiluted	0
	cweb	Earnings Per Proportionate Voting Share Diluted EarningsPerProportionateVotingShareDiluted	-53.49
	cweb	Earnings Per Proportionate Voting Share Diluted EarningsPerProportionateVotingShareDiluted	-53.49
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7716555	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14353465000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.834
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.847
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.033
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q2	us-gaap	Share Price SharePrice	0.31
CY2021Q2	us-gaap	Share Price SharePrice	3.10
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3343883	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.16
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M14D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1039229	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3555188	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.14
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1691112	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.30
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5207959	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M6D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	928368	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1829404	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.49
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y9M29D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	409939	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.14
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.66
	cweb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice	0
	cweb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice	4.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	625000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	628000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2022000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1816851	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.28
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2197676	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.98
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1230658	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	209656	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.98
	cweb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriod	65617	shares
	cweb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriodWeightedAverageGrantDateFairValue	2.29
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2508596	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.22
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	643000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1357000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	5219000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M8D
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0016
CY2020Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1000000000	usd
CY2020Q4	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.0325
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1037000	usd
CY2022Q2	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1037000	usd
CY2021Q1	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000000	usd
CY2021Q2	cweb	Business Combination Purchase Option Extended Term BusinessCombinationPurchaseOptionExtendedTerm	P1Y

Files In Submission

Name	View Source	Status
0001750155-22-000100-index-headers.html	Edgar Link	pending
0001750155-22-000100-index.html	Edgar Link	pending
0001750155-22-000100.txt	Edgar Link	pending
0001750155-22-000100-xbrl.zip	Edgar Link	pending
cweb-20220630.htm	Edgar Link	pending
cweb-20220630.xsd	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cweb-20220630_pre.xml	Edgar Link	unprocessable
cweb-20220630_def.xml	Edgar Link	unprocessable
cweb-20220630_cal.xml	Edgar Link	unprocessable
cweb-20220630_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cweb-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBHF
Stock $cwbhf

2022 Q3 Form 10-Q Financial Statement

#000175015522000100 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBHF Stock $cwbhf

2022 Q3 Form 10-Q Financial Statement

#000175015522000100 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBHF
Stock $cwbhf